FRP-3 Activators
Regarding the chemical class FRP-3 Activators, these are chemicals that can act as indirect activators of FRP-3 (Secreted frizzled-related protein 3) by influencing related pathways or cellular processes, notably the Wnt/β-catenin pathway, MAPK pathway, and PI3K/AKT pathway. These pathways are crucial in several biological processes including cell proliferation, differentiation, and survival. FRP-3, being an antagonist of Wnt proteins, has a significant role in the modulation of these pathways.
The chemicals in this class are either inhibitors or activators of various components of these pathways. For instance, Lithium Chloride, CHIR-99021, JW-55, and Y-27632 are known to activate the Wnt/β-catenin pathway, thereby indirectly influencing FRP-3. On the other hand, SB-431542, PD-0325901, LY-294002, Rapamycin, SP-600125, XAV-939, Roscovitine, and Salinomycin are inhibitors of different components of these pathways, which can indirectly influence FRP-3 by perturbing the balance between pathways or upregulating the Wnt/β-c-catenin signaling. These chemicals act on various targets, including GSK-3 beta, TGF-beta receptors, MEK, ROCK, PI3K, mTOR, JNK, tankyrase, CDKs, and Wnt/β-catenin signaling. Influence on these pathways by these chemicals leads to changes in the activity of FRP-3. For example, chemicals that inhibit components of the Wnt/β-catenin pathway can increase the antagonistic action of FRP-3 on Wnt proteins. Conversely, chemicals that activate the Wnt/β-catenin pathway may lead to a decrease in the antagonistic function of FRP-3. It's important to note that the indirect activation of FRP-3 by these chemicals is a result of their primary action on various other pathway components. The specific effect on FRP-3 will depend upon the balance of these pathways in specific cellular contexts and the degree of modulation by these chemicals.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits GSK3β, a key enzyme in the Wnt/β-catenin pathway that promotes β-catenin degradation. By inhibiting GSK3β, Lithium Chloride can stabilize β-catenin, enhancing the Wnt/β-catenin pathway and indirectly reducing the inhibitory effect of FRP-3. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
BIO is a potent and selective inhibitor of GSK3β, similar to Lithium Chloride. It stabilizes β-catenin, promoting the Wnt/β-catenin pathway and indirectly mitigating the inhibitory role of FRP-3. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin is a flavonoid compound that inhibits the Wnt/β-catenin pathway by promoting β-catenin degradation, similar to Niclosamide. This can indirectly enhance the inhibitory role of FRP-3. | ||||||
JW 55 | 664993-53-7 | sc-364517 sc-364517A | 10 mg 50 mg | $172.00 $726.00 | ||
JW 55 is a small molecule that promotes the interaction between β-catenin and the destruction complex, leading to its degradation and the inhibition of the Wnt/β-catenin pathway. This can indirectly enhance the inhibitory role of FRP-3. | ||||||
Pyrvinium Pamoate | 3546-41-6 | sc-476920A sc-476920 | 250 mg 500 mg | $228.00 $422.00 | ||
Pyrvinium Pamoate is an anthelmintic drug that has been found to inhibit the Wnt/β-catenin pathway by enhancing the activity of casein kinase 1α (CK1α), which promotes β-catenin degradation. This can indirectly enhance the inhibitory role of FRP-3. | ||||||
Cardamonin | 19309-14-9 | sc-293984 sc-293984A | 10 mg 50 mg | $224.00 $940.00 | ||
Cardamonin is a flavonoid compound that inhibits the Wnt/β-catenin pathway by promoting β-catenin degradation, similar to Quercetin and Niclosamide. This can indirectly enhance the inhibitory role of FRP-3. | ||||||
PRI-724 | 1422253-38-0 | sc-507535 | 25 mg | $260.00 | ||
PRI-724 inhibits the interaction between β-catenin and CBP, like ICG-001, inhibiting the Wnt/β-catenin pathway and indirectly enhancing the inhibitory role ofFRP-3. | ||||||